SQI Diagnostics Inc. announced it has appointed Dr. Allan Pronovost to its Board of Directors. SQI will also retain the services of Dr. Pronovost, as strategic advisor, where he will assist the Company in its efforts to secure strategic partnerships and/or additional capital to further advance the Company's IVD and Pharma business units. Dr. Pronovost is currently the President and CSO of Red Lion Chem Tech.

Dr. Pronovost replaces Dr. Peter Lea who has resigned from the Board, effective immediately. Dr. Lea will continue as an active, non-voting senior advisor to the Board.